The Lancet Respiratory Medicine in conversation with
Episodes
Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability
26 Mar 2026
Contributed by Lukas
Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III...
Anne Holland and Christine McDonald
02 Mar 2026
Contributed by Lukas
Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.Click...
Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
22 Dec 2025
Contributed by Lukas
Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia afte...
Sailesh Kotecha on Prematurity-associated lung disease
27 Nov 2025
Contributed by Lukas
Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birt...
Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations
25 Nov 2025
Contributed by Lukas
Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations.cli...
Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change
30 Oct 2025
Contributed by Lukas
Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between cli...
Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
28 Sep 2025
Contributed by Lukas
Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the ...
Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma
28 Sep 2025
Contributed by Lukas
Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal proj...
Joan Soriano on Global Epidemiology of Respiratory Disease
17 Jul 2025
Contributed by Lukas
Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of re...
Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
16 Jul 2025
Contributed by Lukas
Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate...
Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
16 Jul 2025
Contributed by Lukas
This episode is in Italian. For the English version, please see the main feed.Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficaci...
Laura Garriga-Grimau on bronchiectasis in children and young people
02 Jul 2025
Contributed by Lukas
Deputy editor Ari Colosio speaks with Dr. Laura Garriga-Grimau of the Val d’Hebron Hospital, Autonomous University of Barcelona. Dr. Garriga-Grimau ...
Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS
04 Jun 2025
Contributed by Lukas
Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an internatio...
Hjalmar Bouma on sepsis in patients who are immunocompromised
20 May 2025
Contributed by Lukas
Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocomp...
Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019
07 Apr 2025
Contributed by Lukas
Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in ...
Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension
19 Feb 2025
Contributed by Lukas
Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension.Read the fu...
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
25 Oct 2024
Contributed by Lukas
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib c...
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
25 Oct 2024
Contributed by Lukas
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lympha...
Robert Kullberg on empirical antibiotics for Sepsis
11 Oct 2024
Contributed by Lukas
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-a...
Heather Zar on early-life RSV disease and long-term respiratory health
09 Sep 2024
Contributed by Lukas
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be cov...
Margaux Mesle on lives saved by COVID-19 vaccination
07 Aug 2024
Contributed by Lukas
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 20...
James Hull on protecting the respiratory health of athletes
25 Jul 2024
Contributed by Lukas
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paraly...
Eric Lim on treatments for pleural mesothelioma
10 May 2024
Contributed by Lukas
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesotheliom...
Anne Chang on the burden of chronic respiratory diseases in Indigenous people
24 Apr 2024
Contributed by Lukas
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.Read the full article:https://www.thelancet.com/journals/lanre...
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
12 Mar 2024
Contributed by Lukas
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning i...
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
16 Jan 2024
Contributed by Lukas
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated...
Sarah Gorst and Tim Nicholson on long COVID outcomes
02 Nov 2023
Contributed by Lukas
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVI...
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
04 Oct 2023
Contributed by Lukas
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.Read the full article:https://www.thelancet.com/journ...
Keith Chappell on a bivalent recombinant vaccine for COVID-19
13 Sep 2023
Contributed by Lukas
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, v...
James Chalmers on bronchiectasis across Europe
26 Apr 2023
Contributed by Lukas
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible diff...
Richard Costello on management of uncontrolled asthma
21 Mar 2023
Contributed by Lukas
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.C...
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer
06 Mar 2023
Contributed by Lukas
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.Read the full article:Segmentecto...
Carol Hodgson on post-discharge outcomes for ECMO patients
09 Feb 2023
Contributed by Lukas
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.Re...
Emma Grainger on 10 years of The Lancet Respiratory Medicine
22 Dec 2022
Contributed by Lukas
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the j...
Vivienne Kahlmann and Catharina Moor on the TIRED study
23 Nov 2022
Contributed by Lukas
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated w...
Yves Lacasse on long-term oxygen therapy for COPD
31 Jul 2022
Contributed by Lukas
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.Read the...
Rachael Evans on living with long COVID
26 Jul 2022
Contributed by Lukas
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.Read the full article:Physical, cogniti...
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
15 Jun 2022
Contributed by Lukas
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.Read the full Position Paper:A cor...
Daiana Stolz on antibiotic stewardship in pneumonia
24 May 2022
Contributed by Lukas
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Read the full ...
Ablo Wachinou on sleep disordered breathing in Benin
08 Apr 2022
Contributed by Lukas
Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved. Continue this con...
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
07 Apr 2022
Contributed by Lukas
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the re...
Dinh Bui on preterm birth and lung function deficits
18 Feb 2022
Contributed by Lukas
Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53.Continue this conversation ...
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
31 Jan 2022
Contributed by Lukas
Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the ...
Wisia Wedzicha on a vaccine for COPD
11 Jan 2022
Contributed by Lukas
Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research.Read ...
Eileen Rubin on patient-centered ARDS
30 Dec 2021
Contributed by Lukas
Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinic...
Daniel Altmann on COVID boosters
30 Nov 2021
Contributed by Lukas
Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vacci...
Michael Kreuter on interstitial lung disease
06 Sep 2021
Contributed by Lukas
Comment author Michael Kreuter discusses a series of papers published in The Lancet and The Lancet Respiratory Medicine on interstitial lung disease.R...
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
20 Aug 2021
Contributed by Lukas
Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-...
Charles Sprung and authors on end-of-life practices in ICUs globally
03 Aug 2021
Contributed by Lukas
Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end...
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
10 Jul 2021
Contributed by Lukas
Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncon...
Paul Verweij on COVID-19 associated aspergillosis
26 May 2021
Contributed by Lukas
Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.Read the full article:https://www.thelancet.com/jour...
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
17 May 2021
Contributed by Lukas
Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the p...
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
14 May 2021
Contributed by Lukas
Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia.Read the full artic...
Fan Chung on chronic cough and long COVID
11 May 2021
Contributed by Lukas
Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome.Read the full article:https://www.thelancet.com/journals/lanre...
Mepolizumab and the treatment of chronic rhinosinusitis
16 Apr 2021
Contributed by Lukas
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinos...
Inhaled budesonide in the treatment of early COVID-19
15 Apr 2021
Contributed by Lukas
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.Read the full article:ht...
Tocilizumab and COVID-19
05 Mar 2021
Contributed by Lukas
Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-assoc...
Interferon treatment and COVID-19
06 Feb 2021
Contributed by Lukas
Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.Read the full article:https://www.thelancet.com...
Evaluating deterioration in patients with acute COVID-19
12 Jan 2021
Contributed by Lukas
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.Read the full article:https:/...
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
05 Jan 2021
Contributed by Lukas
Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial ...
COVID-19 and severe influenza
18 Dec 2020
Contributed by Lukas
Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. Continue this conversation on s...
The second wave and homeless populations
11 Nov 2020
Contributed by Lukas
Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19...